loadpatents
Patent applications and USPTO patent grants for LIDDLE; John.The latest application filed is for "3-(5-chloro-2-oxobenzo[d]oxazol-3(2h)-yl) propanoic acid derivatives as kmo inhibitors".
Patent | Date |
---|---|
3-(5-chloro-2-oxobenzo[d]oxazol-3(2h)-yl) Propanoic Acid Derivatives As Kmo Inhibitors App 20220298125 - BOUILLOT; Anne Marie Jeanne ;   et al. | 2022-09-22 |
3-(5-chloro-2-oxobenzo[d]oxazol-3(2H)-yl) propanoic acid derivatives as KMO inhibitors Grant 11,352,334 - Bouillot , et al. June 7, 2 | 2022-06-07 |
Benzimidamides compounds comprising an oxaborinin ring Grant 11,352,372 - Liddle , et al. June 7, 2 | 2022-06-07 |
Novel Compounds App 20210276952 - SMITH; Kate ;   et al. | 2021-09-09 |
Novel Benzimidamides Compounds Comprising an Oxaborinin Ring App 20210253604 - LIDDLE; John ;   et al. | 2021-08-19 |
Benzoimidazole derivatives as PAD4 inhibitors Grant 10,815,218 - Amans , et al. October 27, 2 | 2020-10-27 |
Method of treating pancreatitis using 1,4-benzoxazine derivatives Grant 10,611,756 - Bouillot , et al. | 2020-04-07 |
Benzoimidazole Derivatives As Pad4 Inhibitors App 20200095227 - AMANS; Dominique ;   et al. | 2020-03-26 |
3-(5-chloro-2-oxobenzo[d]oxazol-3(2h)-yl) Propanoic Acid Derivatives As Kmo Inhibitors App 20190345117 - BOUILLOT; Anne Marie Jeanne ;   et al. | 2019-11-14 |
Benzoimidazole derivatives as PAD4 inhibitors Grant 10,407,407 - Amans , et al. Sept | 2019-09-10 |
Methods App 20190169178 - BOUILLOT; Anne Marie Jeanne ;   et al. | 2019-06-06 |
3-(6-alkoxy-5-chlorobenzo[D]isoxazol-3-YL)propanoic acid useful as kynurenine monooxygenase inhibitors Grant 10,273,232 - Bouillot , et al. | 2019-04-30 |
Compounds App 20190100517 - Bouillot; Anne Marie Jeanne ;   et al. | 2019-04-04 |
3-(6-chloro-3-oxo-3,4-dihydro-(2H)-1,4-benzoxazin-4-yl) propanoic acid derivatives and their use as KMO inhibitors Grant 10,246,447 - Bouillot , et al. | 2019-04-02 |
Benzoimidazole Derivatives As Pad4 Inhibitors App 20180297983 - Amans; Dominique ;   et al. | 2018-10-18 |
2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors Grant 10,039,755 - Atkinson , et al. August 7, 2 | 2018-08-07 |
3-(6-alkoxy-5-chlorobenzo[d]isoxazol-3-yl)propanoic Acid Useful As Kynurenine Monooxygenase Inhibitors App 20180170921 - BOUILLOT; Anne Marie Jeanne ;   et al. | 2018-06-21 |
3-(6-chloro-3-oxo-3,4-dihydro-(2h)-1,4-benzoxazin-4-yl) Propanoic Acid Derivatives And Their Use As Kmo Inhibitors App 20180170920 - BOUILLOT; Anne Marie Jeanne ;   et al. | 2018-06-21 |
2-(azaindol-2-yl) Benzimidazoles As Pad4 Inhibitors App 20180161316 - Atkinson; Stephen John ;   et al. | 2018-06-14 |
Compounds App 20180127405 - BOUILLOT; Anne Marie Jeanne ;   et al. | 2018-05-10 |
3-(6-alkoxy-5-chlorobenzo[d]isoxazol-3-yl)propanoic acid useful as kynurenine monooxygenase inhibitors Grant 9,932,328 - Bouillot , et al. April 3, 2 | 2018-04-03 |
3-(6-alkoxy-5-chlorobenzo[d]isoxazol-3-yl)propanoic Acid Useful As Kynurenine Monooxygenase Inhibitors App 20170349577 - BOUILLOT; Anne Marie Jeanne ;   et al. | 2017-12-07 |
2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors Grant 9,833,449 - Atkinson , et al. December 5, 2 | 2017-12-05 |
2- (azaindol-2-yl) Benzimidazoles As Pad4 Inhibitors App 20170119750 - Atkinson; Stephen John ;   et al. | 2017-05-04 |
2-(azaindol-2-yl) benz imidazoles as PAD4 inhibitors Grant 9,518,054 - Atkinson , et al. December 13, 2 | 2016-12-13 |
Novel Compounds App 20160355505 - ATKINSON; Francis Louis ;   et al. | 2016-12-08 |
3-(5-chloro-2-oxobenzo[d]oxazol-3(2h)-yl) Propanoic Acid Derivatives As Kmo Inhibitors App 20160318884 - BOUILLOT; Anne Marie Jeanne ;   et al. | 2016-11-03 |
Substituted diketopiperazines and their use as oxytocin antagonists Grant 9,452,169 - Liddle September 27, 2 | 2016-09-27 |
Compounds Grant 9,447,074 - Atkinson , et al. September 20, 2 | 2016-09-20 |
Compounds Grant 9,408,851 - Borthwick , et al. August 9, 2 | 2016-08-09 |
Substituted Diketopiperazines And Their Use As Oxytocin Antagonists App 20160074413 - Liddle; John | 2016-03-17 |
Novel Compounds App 20160030442 - Borthwick; Alan David ;   et al. | 2016-02-04 |
2 - (azaindol-2-yl) Benz Imidazoles As Pad4 Inhibitors App 20160009716 - Atkinson; Stephen John ;   et al. | 2016-01-14 |
2-(azaindol-2-yl)benzimidazoles as PAD4 inhibitors Grant 9,127,003 - Atkinson , et al. September 8, 2 | 2015-09-08 |
2-(azaindol-2-yl)benzimidazoles As Pad4 Inhibitors App 20150175600 - Atkinson; Stephen John ;   et al. | 2015-06-25 |
Novel Compounds App 20150166508 - ATKINSON; Francis Louis ;   et al. | 2015-06-18 |
Novel Compounds App 20150157640 - Borthwick; Alan David ;   et al. | 2015-06-11 |
Substituted Diketopiperazines And Their Use As Oxytocin Antagonists App 20150105387 - Liddle; John | 2015-04-16 |
Compounds Grant 8,993,560 - Atkinson , et al. March 31, 2 | 2015-03-31 |
Substituted diketopiperazines and their use as oxytocin antagonists Grant 8,937,179 - Liddle January 20, 2 | 2015-01-20 |
Compounds Grant 8,742,099 - Borthwick , et al. June 3, 2 | 2014-06-03 |
Substituted Diketopiperazines And Their Use As Oxytocin Antagonists App 20140058105 - Liddle; John | 2014-02-27 |
7-(1H-pyrazol-4-yl)-1,6-naphthyridine compounds as Syk inhibitors Grant 8,633,319 - Atkinson , et al. January 21, 2 | 2014-01-21 |
Pyrido[3,4-b]pyrazine Derivatives As Syk Inhibitors App 20140005188 - Atkinson; Francis Louis ;   et al. | 2014-01-02 |
Pyridinyl- And Pyrazinyl-methyloxy-aryl Derivatives Useful As Inhibitors Of Spleen Tyrosine Kinase (syk) App 20140005177 - Atkinson; Francis Louis ;   et al. | 2014-01-02 |
Novel Compounds App 20130253188 - Borthwick; Alan David ;   et al. | 2013-09-26 |
Substituted diketopiperazines as oxytocin antagonists Grant 8,541,579 - Borthwick , et al. September 24, 2 | 2013-09-24 |
Substituted Diketopiperazines As Oxytocin Antagonists App 20130131338 - Borthwick; Alan David ;   et al. | 2013-05-23 |
Substituted Diketopiperazines And Their Use As Oxytocin Antagonists App 20130102783 - Liddle; John | 2013-04-25 |
7-(lH-PYRAZOL-4-YL)-1,6-NAPHTHYRIDINE COMPOUNDS AS SYK INHIBITORS App 20130040984 - Atkinson; Francis Louis ;   et al. | 2013-02-14 |
Substituted diketopiperazines as oxytocin antagonists Grant 8,367,673 - Borthwick , et al. February 5, 2 | 2013-02-05 |
Substituted diketopiperazines and their use as oxytocin antagonists Grant 8,357,685 - Liddle January 22, 2 | 2013-01-22 |
Novel Compounds App 20120232061 - Atkinson; Francis Louis ;   et al. | 2012-09-13 |
Novel Compounds App 20120202811 - Borthwick; Alan David ;   et al. | 2012-08-09 |
Compounds Grant 8,202,864 - Borthwick , et al. June 19, 2 | 2012-06-19 |
Substituted Diketopiperazines And Their Use As Oxytocin Antagonists App 20120004229 - Liddle; John | 2012-01-05 |
Substituted diketopiperazines and their use as oxytocin antagonists Grant 8,071,594 - Liddle December 6, 2 | 2011-12-06 |
Novel Compounds App 20110152262 - Borthwick; Alan David ;   et al. | 2011-06-23 |
Compounds Grant 7,919,492 - Borthwick , et al. April 5, 2 | 2011-04-05 |
Novel Compounds App 20100305127 - Borthwick; Alan David ;   et al. | 2010-12-02 |
Xanthine Derivatives As Selective Hm74a Agonists App 20100179128 - Hatley; Richard Jonathan Daniel ;   et al. | 2010-07-15 |
Pyrrolopyridine Compounds, Process For Their Preparation, And Their Use As Medicaments App 20100179139 - Bamborough; Paul ;   et al. | 2010-07-15 |
Pyrrolo[2,3-b]pyridin-4-yl-benzenesulfonamide Compounds As 1kk2 Inhibitors App 20100035917 - Bamborough; Paul ;   et al. | 2010-02-11 |
Novel compounds App 20090247541 - Borthwick; Alan David ;   et al. | 2009-10-01 |
Substituted Diketopiperazines As Oxytocin Antagonists App 20090186867 - Borthwick; Alan David ;   et al. | 2009-07-23 |
Piperazinediones as oxytocin receptor antagonists Grant 7,550,462 - Borthwick , et al. June 23, 2 | 2009-06-23 |
Substituted diketopiperazines as oxytocin antagonists Grant 7,514,437 - Borthwick , et al. April 7, 2 | 2009-04-07 |
1-6-Substituted (3R,6R)-3-(2,3-Dihydro-1H-Inden-2-Yl)-2,5-Piperazinedione Derivatives as Oxytocin Receptor Antagonists For the Treatment of Preterm Labour, Dysmenorrhea and Endometriosis App 20080242666 - Leach; Colin Andrew ;   et al. | 2008-10-02 |
Novel Compounds App 20080176891 - Bamborough; Paul ;   et al. | 2008-07-24 |
Novel Compounds App 20080146606 - Bamborough; Paul ;   et al. | 2008-06-19 |
Pyrazolopyridines and pyrazolopyridazines as antidiabetics Grant 7,297,792 - Garland , et al. November 20, 2 | 2007-11-20 |
Piperazinediones as Oxytocin Receptor Antagonists App 20070254888 - Borthwick; Alan David ;   et al. | 2007-11-01 |
Substituted diketopiperazines as oxytocin receptor antagonists App 20070185162 - Borthwick; Alan David ;   et al. | 2007-08-09 |
Substituted diketopiperazines and their use as oxytocin antagonists App 20070149524 - Liddle; John | 2007-06-28 |
Pyridinone derivatives for treatment of atherosclerosis Grant 7,235,566 - Hickey , et al. June 26, 2 | 2007-06-26 |
Pyrazolopyridines And Pyrazolopyridazines Adn Antidiabetics App 20060223800 - Garland; Stephen ;   et al. | 2006-10-05 |
Pyrazolopyridines and pyrazolopyridazines as antidiabetics Grant 7,109,199 - Garland , et al. September 19, 2 | 2006-09-19 |
Substituted diketopiperazines as oxytocin antagonists App 20050148572 - Borthwick, Alan David ;   et al. | 2005-07-07 |
Heterocyclic derivatives of glycinamide and their medical use App 20050043335 - Elliott, Richard Leonard ;   et al. | 2005-02-24 |
Pyridone, pyridazone and triazone derivatives as lp-pla2 inhibitors App 20050020832 - Fell, Stephen Christopher Martin ;   et al. | 2005-01-27 |
Pyridinone derivatives for treatment of atherosclerosis App 20050014793 - Hickey, Deirdre Mary Bernadette ;   et al. | 2005-01-20 |
Pyridinone derivatives for treatment of atherosclerosis App 20040063753 - Hickey, Deirdre Mary Bernadette ;   et al. | 2004-04-01 |
Pyrazolopyridines and pyrazolopyridazines as antidabetics App 20040019052 - Garland, Stephen ;   et al. | 2004-01-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.